Literature DB >> 8808604

Genetic homogeneity of autoimmune polyglandular disease type I.

P Björses1, J Aaltonen, A Vikman, J Perheentupa, G Ben-Zion, G Chiumello, N Dahl, P Heideman, J J Hoorweg-Nijman, L Mathivon, P E Mullis, M Pohl, M Ritzen, G Romeo, M S Shapiro, C S Smith, J Solyom, J Zlotogora, L Peltonen.   

Abstract

Autoimmune polyglandular disease type I (APECED) is an autosomal recessive autoimmune disease (MIM 240300) characterized by hypoparathyroidism, primary adrenocortical failure, and chronic mucocutaneous candidiasis. The disease is highly prevalent in two isolated populations, the Finnish population and the Iranian Jewish one. Sporadic cases have been identified in many other countries, including almost all European countries. The APECED locus has previously been assigned to chromosome 21q22.3 by linkage analyses in 14 Finnish families. Locus heterogeneity is a highly relevant question in this disease affecting multiple tissues and with great phenotypic diversity. To solve this matter, we performed linkage and haplotype analyses on APECED families rising from different populations. Six microsatellite markers on the critical chromosomal region of 2.6 cM on 21q22.3 were analyzed. Pairwise linkage analyses revealed significant LOD scores for all these markers, maximum LOD score being 10.23. The obtained haplotype data and the geographic distribution of the great-grandparents of the Finnish APECED patients suggest the presence of one major, relatively old mutation responsible for approximately 90% of the Finnish cases. Similar evidence for one founder mutation was also found in analyses of Iranian Jewish APECED haplotypes. These haplotypes, however, differed totally from the Finnish ones. The linkage analyses in 21 non-Finnish APECED families originating from several European countries provided independent evidence for linkage to the same chromosomal region on 21q22.3 and revealed no evidence for locus heterogeneity. The haplotype analyses of APECED chromosomes suggest that in different populations APECED is due to a spectrum of mutations in a still unknown gene on chromosome 21.

Entities:  

Mesh:

Year:  1996        PMID: 8808604      PMCID: PMC1914815     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Infantile neuronal ceroid lipofuscinosis (CLN1): linkage disequilibrium in the Finnish population and evidence that variant late infantile form (variant CLN2) represents a nonallelic locus.

Authors:  I Järvelä
Journal:  Genomics       Date:  1991-06       Impact factor: 5.736

2.  The age of human mutation: genealogical and linkage disequilibrium analysis of the CLN5 mutation in the Finnish population.

Authors:  T Varilo; M Savukoski; R Norio; P Santavuori; L Peltonen; I Järvelä
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

3.  Spectrum of mutations in aspartylglucosaminuria.

Authors:  E Ikonen; P Aula; K Grön; O Tollersrud; R Halila; T Manninen; A C Syvänen; L Peltonen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

4.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.

Authors:  K B Mullis; F A Faloona
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Integration of gene maps: chromosome 21.

Authors:  S Lawrence; A Collins; B J Keats; M Hulten; N E Morton
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

6.  Localization of the EPM1 gene for progressive myoclonus epilepsy on chromosome 21: linkage disequilibrium allows high resolution mapping.

Authors:  A E Lehesjoki; M Koskiniemi; R Norio; S Tirrito; P Sistonen; E Lander; A de la Chapelle
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

7.  Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

Authors:  P Ahonen; S Myllärniemi; I Sipilä; J Perheentupa
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR.

Authors:  P Ahonen; S Koskimies; M L Lokki; A Tiilikainen; J Perheentupa
Journal:  J Clin Endocrinol Metab       Date:  1988-06       Impact factor: 5.958

10.  Polyglandular autoimmune syndrome type I among Iranian Jews.

Authors:  J Zlotogora; M S Shapiro
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

View more
  20 in total

Review 1.  Autoimmune polyglandular syndrome type 1.

Authors:  P Obermayer-Straub; C P Strassburg; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

Review 3.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity.

Authors:  P Peterson; J Pitkänen; N Sillanpää; K Krohn
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 4.  Genetic Disorders of Parathyroid Development and Function.

Authors:  Rebecca J Gordon; Michael A Levine
Journal:  Endocrinol Metab Clin North Am       Date:  2018-10-12       Impact factor: 4.741

5.  [Clinical analysis and autoimmune regulator gene mutation of autoimmune polyendocrinopathy syndrome type I in a family: a report of one case].

Authors:  Yong-Xiang Sun; Ya-Fei He; Xia-Lian Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-02

6.  Mutations in the AIRE gene: effects on subcellular location and transactivation function of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protein.

Authors:  P Björses; M Halonen; J J Palvimo; M Kolmer; J Aaltonen; P Ellonen; J Perheentupa; I Ulmanen; L Peltonen
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

7.  Changes in expression of IL-1 beta influenced proteins in transplanted islets during development of diabetes in diabetes-prone BB rats.

Authors:  T Sparre; U Bjerre Christensen; C F Gotfredsen; P Mose Larsen; S J Fey; K Hjernø; P Roepstorff; F Pociot; A E Karlsen; J Nerup
Journal:  Diabetologia       Date:  2004-04-23       Impact factor: 10.122

8.  Sicilian family with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) and lethal lung disease in one of the affected brothers.

Authors:  Filippo De Luca; Mariella Valenzise; Rita Alaggio; Teresa Arrigo; Giuseppe Crisafulli; Giuseppina Salzano; Sara Cervato; Barbara Mariniello; Francesca Lazzarotto; Corrado Betterle
Journal:  Eur J Pediatr       Date:  2008-02-15       Impact factor: 3.183

9.  A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1.

Authors:  S H Pearce; T Cheetham; H Imrie; B Vaidya; N D Barnes; R W Bilous; D Carr; K Meeran; N J Shaw; C S Smith; A D Toft; G Williams; P Kendall-Taylor
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

10.  Asplenia and functional hyposplenism in autoimmune polyglandular syndrome type 1.

Authors:  Uri Pollak; Zvi Bar-Sever; Vered Hoffer; Nufar Marcus; Oded Scheuerman; Ben Zion Garty
Journal:  Eur J Pediatr       Date:  2008-05-22       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.